Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Alcoholic Steatohepatitis (NASH)”

1,746 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,746 results

Not applicableStudy completedNCT07269197
What this trial is testing

Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Josip Juraj Strossmayer University of Osijek 67
Not applicableStudy completedNCT06443723
What this trial is testing

Metabolic Dysfunction Associated Fatty Liver Disease in Long-Term Cholecystectomy Patients

Who this might be right for
Liver Steatoses
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital 149
Post-approval studies (Phase 4)Study completedNCT04537780
What this trial is testing

Efficacy and Safety of Montelukast in Non Alcoholic Steatohepatitis (NASH)

Who this might be right for
Non Alcoholic Steatohepatitis
Tanta University 44
Not applicableStudy completedNCT00280527
What this trial is testing

Protocol for the Assessment of Variability in Histology and Gene Expression in Bariatric Surgery Patients.

Who this might be right for
Obesity
Northwestern University 43
Large-scale testing (Phase 3)UnknownNCT02265276
What this trial is testing

A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease

Who this might be right for
Fatty Liver
Command Hospital, India 100
Testing effectiveness (Phase 2)Study completedNCT03118310
What this trial is testing

Treatment of NAFLD With Two Different Diets

Who this might be right for
NAFLD
Karolinska University Hospital 74
Testing effectiveness (Phase 2)Looking for participantsNCT05480696
What this trial is testing

Soluble Fibre Supplementation in NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon Alcoholic SteatohepatitisHepatic Steatosis
McMaster University 60
Not applicableNot Yet RecruitingNCT06341790
What this trial is testing

Effect of Consumption of Millet Diet in Patients With NAFLD

Who this might be right for
NAFLD
Institute of Liver and Biliary Sciences, India 60
Large-scale testing (Phase 3)Looking for participantsNCT07265297
What this trial is testing

Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis

Who this might be right for
Steatohepatitis, Nonalcoholic
National Taiwan University Hospital 210
Post-approval studies (Phase 4)Active Not RecruitingNCT06918080
What this trial is testing

Hepatoprotective Measures for Children at High Risk of NAFLD

Who this might be right for
Non Alcoholic Fatty Liver Diseases (NAFLD)Obesity and OverweightAcute Lymphoblastic Leukemia
Ain Shams University 200
Not applicableEnded earlyNCT04440540
What this trial is testing

Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based Study

Who this might be right for
Non-alcoholic Fatty Liver Disease
Chinese University of Hong Kong 10
Testing effectiveness (Phase 2)Ended earlyNCT03436420
What this trial is testing

Gemcabene for the Treatment of Pediatric NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Emory University 6
Not applicableStudy completedNCT06195943
What this trial is testing

Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
NASH - Nonalcoholic SteatohepatitisNASHExercise+1 more
Milton S. Hershey Medical Center 17
Post-approval studies (Phase 4)UnknownNCT03648554
What this trial is testing

Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)

Who this might be right for
Diabetes Mellitus, Type 2NASH - Nonalcoholic Steatohepatitis
Central Hospital, Nancy, France 93
Not applicableStudy completedNCT00523562
What this trial is testing

Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity

Who this might be right for
Metabolic Syndrome XLiver Diseases
University of Lausanne 41
Testing effectiveness (Phase 2)Study completedNCT01913470
What this trial is testing

Study of Losartan in the Treatment of NAFLD in Children

Who this might be right for
NAFLD
Miriam Vos, MD 12
Very early researchStudy completedNCT05720702
What this trial is testing

A Feasibility Trial of OCM Supplements for the Treatment of NAFLD

Who this might be right for
NAFLD
Duke University 31
Testing effectiveness (Phase 2)Study completedNCT04198805
What this trial is testing

Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-Alcoholic Fatty LiverNon-Alcoholic Steatohepatitis
Naga P. Chalasani 205
Post-approval studies (Phase 4)WithdrawnNCT02973295
What this trial is testing

Silymarin in NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University Hospital Rijeka
Not applicableUnknownNCT05790057
What this trial is testing

Subclinical Cardiovascular Changes in NAFLD Patient (Predictive Value of Speckle Tracking Echocardiography )

Who this might be right for
Liver Steatoses
Assiut University 60
Load More Results